Hyaluronic Acid Filler Injection for Localized Scleroderma – Case Report and Review of Literature on Filler Injections for Localized Scleroderma

References

• Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KE. Dermatology in General Medicine. McGraw Hill Medical. 1987: 1841–1852.
   Google Scholar
• Zancanaro PC, Isaac AR, Garcia LT, Costa IM. Localized scleroderma in children: clinical, diagnostic, and therapeutic aspects. An Bras Dermatol. 2009;84(2):161–172.
   PubMed Web of Science ®Google Scholar
• Peterson LS, Nelson AM, Su WP, Mason T, O’Fallon WM, Gabriel SE. The epidemio- logy of morphea (localized scleroderma) in Olmstead Country 1960–1993. J Rheumatol. 1997;24:73–80.
   PubMed Web of Science ®Google Scholar
• Zulian F, Athreya BH, Laxer R, Nelson AM. Juvenile localized scleroderma: clinical and epidemiological features in 750 chil- dren. An international study. Rheumatology. 2006;45:614–620.
   PubMed Web of Science ®Google Scholar
• Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol. 2009;145:545–550.
   PubMedGoogle Scholar
• Fett N, Werth VP. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2011;64:217–228.
   PubMed Web of Science ®Google Scholar
• Christen-Zaech S, Hakim MD, Afsar FS, Paller AS. Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol. 2008;59:385–396.
   PubMed Web of Science ®Google Scholar
• Matsuura K, Umebayashi Y, Otsuka F. Computed tomography reveals thickened subcutaneous tissue in scleroderma. Br J Dermatol. 1997;137:1015–1016.
   PubMed Web of Science ®Google Scholar
• Freedberg IM, Eisen AZ, Wolff K, et al.. Fitzpatrick Dermatology in General Medicine. 6th ed. Vol. 2. New York: McGraw Hill; 2003: 1709–1718.
   Google Scholar
• Zulian F, Culpo R, Sperotto F, et al.. Consensus-based recommendations for the management of juvenile localised scleroderma. Ann Rheum Dis. 2019;78(8):1019–1024. doi:10.1136/annrheumdis-2018-214697
   PubMed Web of Science ®Google Scholar
• Zwischenberger BA, Jacobe HT. A systematic review of morphea treatments and therapeutic algorithm. J Am Acad Dermatol. 2011;65:925–941.
   PubMed Web of Science ®Google Scholar
• Kroft EB, Berkhof NJ, van de Kerkhof PC, Gerritsen RM, de Jong EM. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol. 2008;59:1017–1030.
   PubMed Web of Science ®Google Scholar
• Kineston D, Kwan JM, Uebelhoer NS, Shumaker PR. Use of a fractional ablative 10.6- μm carbon dioxide laser in the treatment of a morphea-related contracture. Arch Dermatol. 2011;147:1148–1150.
   PubMedGoogle Scholar
• Hawk A, English JC. Localized and systemic scleroderma. Semin Cutan Med Surg. 2001;20:27.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lim SY, Lee JH, Ahn HC. Surgical management of localized scleroderma. Arch Craniofac Surg. 2017;18(3):166–171.
   PubMedGoogle Scholar
• Sengezer M, Deveci M, Selmanpakoglu N. Repair of the ”coup de sabre,” a linear form of scleroderma. Ann Plast Surg. 1996;37(4):428–432.
   PubMed Web of Science ®Google Scholar
• Oh CK, Lee J, Jang BS, et al. Treatment of secondary atrophies to trilinear scleroderma in coup de sabre by injection of an autologous tissue cocktail. Dermatol Surg. 2003;29:1073–1075.
   Google Scholar
• Lapiere JC, Aasi S, Cook B, et al. Successful correction of forehead depressed scars secondary to trauma and morphea in coup de sabre by in-block autologous dermal fat graft. Dermatol Surg. 2000;26:793–797.
   Google Scholar
• Robitschek J, Wang D, Hall D. Treatment of linear scleroderma en coup de sabre with AlloDerm tissue matrix. Otolaryngol Head Neck Surg. 2008;138:540–541.
   Google Scholar
• Lane TK, Cheung J, Schaffer JV. Parry-Romberg syndrome with coexistent morphea. Dermatol Online J. 2008;14:21.
   Google Scholar
• Choksi A, Orrigner J. Linear morphea-induced atrophy treated with hyaluronic acid filler injections. Derm Surg. 2011;37:880–883.
   Google Scholar
• Mashiko T, Mori H, Kato H, et al. Semipermanent volumization by an absorbable filler: onlay injection technique to the bone. Plast Reconstr Surg Glob Open. 2013;1(1):e4–e14.
   Google Scholar
• Thareja SK, Sadhwani D, Alan Fenske N. En coup de sabre morphea treated with hyaluronic acid filler. Report of a case and review of the literature. Int J Dermatol. 2015;54(7):823–826.
   Google Scholar
• Arsiwala SZ. Persistence of hyaluronic acid filler for subcutaneous atrophy in the case of circumscribed scleroderma. J Cutan Aesthet Surg. 2015;8(1):69–71.
   Google Scholar
• Walls A, Goldberg D, Foley E, Makredes M. Correction of morphea en coup de sabre with hyaluronic acid filler. J Am Acad Dermatol. 2012;66(4):AB209.
   Google Scholar
• Sivek R, Emer J. Use of a blunt-tipped microcannula for soft tissue filler injection in the treatment of linear scleroderma (en coup de sabre). Dermatol Surg. 2014;40(12):1439–1441.
   Google Scholar
• Jo M, Ahn H, Ju H, et al.. Parry-Romberg syndrome augmented by hyaluronic acid filler. Ann Dermatol. 2018;30(6):704–707. doi:10.5021/ad.2018.30.6.704
   Google Scholar
• Sharquie KE, Fatema A, Al-Jaralla IKS. Intralesional injection of hyaluronic acid as a long-lasting therapy of morphea sclerosis. Am J Dermatol Venereol. 2019;8(3):45–48.
   Google Scholar
• Pirrello R, Verro B, Grasso G, et al. Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study. Arthritis Res Ther. 2019;21:286. doi:10.1186/s13075-019-2062-0
   Google Scholar
• Owczarczyk-Saczonek A, Kasprowicz-Furmaczyk M, Kruszewska A, et al. Correction of facial morphea lesions by hyaluronic acid: a case series and literature review. Dermatol Ther. 2020;10(6):1423–1434.
   Google Scholar
• Carruthers A, Carruthers J. Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus. Dermatol Surg. 2008;34:1486–1499.
   Google Scholar
• Onesti MG, Troccola A, Scuderi N. Volumetric correction using poly-L-lactic acid in facial asymmetry: parry Romberg syndrome and scleroderma. Dermatol Surg. 2009;35:1368–1375.
   Google Scholar
• Cox SE, Soderberg JM. Idiopathic hemifacial atrophy treated with serial injections of calcium hydroxylapatite. Dermatol Surg. 2010;34:542–545.
   Google Scholar
• Franco JPA, Serra MS, Lima RB, D’acri AM, Martins CJ. Scleroderma in coup de sabre treated with polymethylmethacrylate - Case report. Bras Dermatol. 2016;91(2):209–211.
   Google Scholar
• Kim J, Kim J, Lee YI, Lee JH. Treatment of linear morphea (en coup de sabre) with micronized acellular dermal matrix filler: a case report. Ann Dermatol. 2021;33(4):373–376. doi:10.5021/ad.2021.33.4.373
   Google Scholar
• Bader RS, Johnson DL Dermal fillers; 2008. Available from: http://emedicine.medscape.com/article/5066-overview. Accessed August 8, 2022.
   Google Scholar
• Wang F, Garza L, Kang S, et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol. 2007;143:155–163.
   Google Scholar
• Gold MH. Use of hyaluronic acid fillers for the treatment of the ageing face. Clin Interv Aging. 2007;2(3):369–376. doi:10.2147/cia.s1244
   Google Scholar
• Nilforoushzadeh MA, Lotfi E, Heidari-Kharaji M, Nickhah N, Alavi S, Mahmoudbeyk M. Comparing cannula-based subcision with the common needle method: a clinical trial. Skin Res Technol. 2020;26(1):39–44. doi:10.1111/srt.12761
   Google Scholar
• Creadore A, Watchmaker J, Maymone MBC, Pappas L, Lam C, Vashi NA. Cosmetic treatment in patients with autoimmune connective tissue diseases: best practices for patients with morphea/systemic sclerosis. J Am Acad Dermatol. 2020;83(2):315–341. doi:10.1016/j.jaad.2019.12.081
   Google Scholar
• Buense R, Duarte IAG, Bouer M. Localized scleroderma: assessment of the therapeutic response to phototherapy. Bras Dermatol. 2012;87(1):63–69.
   Google Scholar